Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population
Open Access
- 21 February 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Perinatology
- Vol. 28 (5), 324-329
- https://doi.org/10.1038/jp.2008.6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Safety of medications prescribed before and during early pregnancy in a cohort of 81 975 mothers from the UK General Practice Research DatabasePharmacoepidemiology and Drug Safety, 2006
- National patterns of medication use during pregnancyPharmacoepidemiology and Drug Safety, 2006
- Selective serotonin reuptake inhibitors and adverse pregnancy outcomesAmerican Journal of Obstetrics and Gynecology, 2006
- Maternal medicine: Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy‐related drugs in the NetherlandsBJOG: An International Journal of Obstetrics and Gynaecology, 2006
- Use of prescription medications with a potential for fetal harm among pregnant womenPharmacoepidemiology and Drug Safety, 2006
- Prescription drug use in pregnancyAmerican Journal of Obstetrics and Gynecology, 2004
- Thalidomide: Tragic Past and Promising FutureMayo Clinic Proceedings, 2004
- Adverse Outcomes in Pregnancies of Asthmatic Women: Results from a Canadian PopulationAnnals of Epidemiology, 2001
- Prescribing during pregnancy and lactation with reference to the Swedish classification system, A population‐based study among Danish womenActa Obstetricia et Gynecologica Scandinavica, 1999
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992